Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00424190 · ClinicalTrials.gov registry record · Phase 3
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
A Phase 3 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 698
- Enrollment target
NCT00424190 is a Phase 3 study that has completed, run by Forest Laboratories. The registered enrollment target is 698 participants.
The verdict
NCT00424190, a Phase 3 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 698 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.
Interventions
- DRUG Ceftaroline
- DRUG IV Vancomycin plus IV Aztreonam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 698 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00424190
The ClinicalTrials.gov registry entry for NCT00424190 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ceftaroline is the first listed.
NCT00424190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00424190 about?
NCT00424190 is a clinical study titled "Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections". The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.
What is the current status of trial NCT00424190?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 698 participants. The study started on 2007-02. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00424190?
The interventions under investigation include: Ceftaroline (DRUG), IV Vancomycin plus IV Aztreonam (DRUG).
Who is sponsoring clinical trial NCT00424190?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.